• News
  • Technology

Tandem Diabetes Care acquires ownership of 23 patents

Tandem Diabetes Care Inc. announced Friday that it has acquired ownership of at least 23 U.S. patents and patent applications relating to the treatment of diabetes from Smiths Medical ASD Inc.

As part of the transaction, Tandem has also obtained a license to 28 other U.S. patents and patent applications owned by Smiths Medical, Tandem said in a release.

According to the company, the license affords it exclusive access to technologies useful for future product development in the field of ambulatory infusion pumps and related software and accessories for the treatment of diabetes.


J&J diabetes pill may cause heart risk, FDA staff says

Sanofi diabetes treatment Lyxumia wins EU panel recommendation

Salk study finds diabetes raises levels of proteins linked to Alzheimer's features

User Response
0 UserComments